Episode 485: Journal Club Including Fellow Eye PVD, Can You Compare Syfovre and Izervay?, and Litigation Involving Intravitreal Injections

NOV 17, 2025-1 MIN
Straight From The Cutter's Mouth: A Retina Podcast

Episode 485: Journal Club Including Fellow Eye PVD, Can You Compare Syfovre and Izervay?, and Litigation Involving Intravitreal Injections

NOV 17, 2025-1 MIN

Description

<p class="is-empty is-editor-empty" data-rte-preserve-empty="true" style="white-space:pre-wrap;">‍ ‍</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Drs. Akshay Thomas and Sarwar Zahid join for a journal club episode discussion of three recent publications:</p><p class="is-empty is-editor-empty" data-rte-preserve-empty="true" style="white-space:pre-wrap;">‍ ‍</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">&nbsp;</p><p class="is-empty is-editor-empty" data-rte-preserve-empty="true" style="white-space:pre-wrap;">‍ ‍</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Fellow Eye PVD (<a href="https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fjournals.sagepub.com%2Fdoi%2Ffull%2F10.1177%2F24741264251379842&amp;data=05%7C02%7Cjustin.zhang%40som.umaryland.edu%7Cb97e3a5136424d1b1acb08de23f86d6b%7C717009a620de461a88940312a395cac9%7C0%7C0%7C638987747508096499%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=ww5hsTc3VZjyszbaVmpDrrczHgRPEqae0uw9CVToIWc%3D&amp;reserved=0">https://journals.sagepub.com/doi/full/10.1177/24741264251379842</a>)</p><p class="is-empty is-editor-empty" data-rte-preserve-empty="true" style="white-space:pre-wrap;">‍ ‍</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Syfovre versus Izervay (<a href="https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fjournals.sagepub.com%2Fdoi%2Ffull%2F10.1177%2F24741264251379842&amp;data=05%7C02%7Cjustin.zhang%40som.umaryland.edu%7Cb97e3a5136424d1b1acb08de23f86d6b%7C717009a620de461a88940312a395cac9%7C0%7C0%7C638987747508118605%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=g%2F6D6V6FWNyuzvmY1X6sXp65yOjJHhI1kM8iSvzcxm8%3D&amp;reserved=0">https://journals.sagepub.com/doi/full/10.1177/24741264251379842</a>)</p><p class="is-empty is-editor-empty" data-rte-preserve-empty="true" style="white-space:pre-wrap;">‍ ‍</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Litigation Involving Intravitreal Injections (<a href="https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.ophthalmologyretina.org%2Farticle%2FS2468-6530(25)00439-7%2Fabstract&amp;data=05%7C02%7Cjustin.zhang%40som.umaryland.edu%7Cb97e3a5136424d1b1acb08de23f86d6b%7C717009a620de461a88940312a395cac9%7C0%7C0%7C638987747508136711%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=ZHWaVoGU30KCNbojKSxL7REyKPbuoMKP5sggqKr%2Bsrk%3D&amp;reserved=0">https://www.ophthalmologyretina.org/article/S2468-6530(25)00439-7/abstract</a>)</p><p class="is-empty is-editor-empty" data-rte-preserve-empty="true" style="white-space:pre-wrap;">‍ ‍</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">&nbsp;</p><p class="is-empty is-editor-empty" data-rte-preserve-empty="true" style="white-space:pre-wrap;">‍ ‍</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Disclosures: Dr. Sridhar has consulted for Apellis and Astellas in the past 3 years.&nbsp;</p><p data-rte-preserve-empty="true" style="white-space:pre-wrap;">‍ ‍</p>